Turkish adaptation of the Cybersickness in Virtual Reality Questionnaire (CSQ-VR)
Turkish Validity and Reliability of CyberSickness in Virtual Reality Questionnaire
This project tests whether a Turkish version of the CSQ-VR questionnaire reliably measures cybersickness symptoms in healthy volunteers who use virtual reality.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 42 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | Abant Izzet Baysal University Academic / other |
| Locations | 1 site (Bolu, Bolu) |
| Trial ID | NCT07247773 on ClinicalTrials.gov |
What this trial studies
The study adapts the CSQ-VR into Turkish and recruits healthy volunteers at Abant Izzet Baysal University to complete the questionnaire after VR exposure. Participants are screened for normal binocular 3D vision and must be able to stand and walk independently, with those failing the Titmus stereotest excluded. Data will be analyzed for reliability (e.g., internal consistency, test-retest) and validity (e.g., construct and convergent validity) to determine whether the Turkish CSQ-VR measures cybersickness consistently and accurately. The study situates the instrument within existing theories of cybersickness such as sensory conflict and vection as background for interpretation.
Who should consider this trial
Good fit: Ideal participants are healthy adults who can stand and walk independently, have normal binocular 3D vision, and consent to testing including the Titmus stereotest.
Not a fit: People with amblyopia, strabismus, other vision pathologies that impair depth perception, or who cannot attend the on-site assessments are unlikely to benefit directly from this validation.
Why it matters
Potential benefit: If successful, the Turkish CSQ-VR could give researchers and VR developers a reliable tool to identify and reduce cybersickness in Turkish-speaking users.
How similar studies have performed: Similar questionnaire adaptation and validation studies for cybersickness and simulator sickness have been conducted successfully in other languages, though a Turkish CSQ-VR is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntary agreement to participate in the study * Ability to stand and walk independently Exclusion Criteria: * Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision * Failure on the butterfly test of the Titmus stereotest
Where this trial is running
Bolu, Bolu
- Abant Izzet Baysal University Faculty of Health Science — Bolu, Bolu, Turkey (Türkiye) (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.